IP Library Granted Patent US 9,012,508
Granted Patent B2
US 9,012,508 · App. 12/722,682 · Granted Apr 21, 2015

Administration of intravenous ibuprofen

Inventor: Leo Pavliv (Cary, NC)
Assignee: Cumberland Pharmaceuticals
A61K31/192A61K31/485
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,012,508
App. No.
12/722,682
Granted
Apr 21, 2015
Kind
B2
Abstract

An effective dose of intravenous ibuprofen administered every 6 hours in surgery patients is a safe and effective way to reduce both pain and the need for morphine. In preferred embodiments, the administration of intravenous ibuprofen starts with the onset of anesthesia.

Claims (8)

1. A method for reducing surgical pain in human patients, consisting of

(i) treating post-surgical pain by administering a first dose of intravenous ibuprofen solution in an amount of about 800 mg prior to the start of surgery on the patients,

(ii) intravenously administering a further dose of 800 mg dose of intravenous ibuprofen about every six hours post-operatively to the patients at least until 24 hours after surgery and about every 6 hours from about 24 hours after surgery up to about 5 days after surgery; and

(iii) administering morphine, an opioid analgesic, post-operatively to the patients in an amount which is reduced by about 20% or more within the first 24 hours after surgery than that typically required to control pain in human patients having undergone the same surgical procedure without said administration of ibuprofen, such that the human patients receiving intravenous ibuprofen experience about a 30% reduction in mean morphine consumption.

2. The method of claim 1 , wherein the patients experience a significant reduction in pain as measured by the VAS with movement and/or the VAS at rest area under the curve for time points within the first 24 hours after surgery.

3. The method of claim 1 , provides a reduction in side effects associated with the administration of opioid analgesics.

4. The method of claim 1 , wherein the patient undergoes a surgical procedure selected from orthopedic surgery, gynecologic surgery, major abdominal surgery, lower abdominal, and general investigative surgery.

5. The method of claim 1 , wherein the ibuprofen being intravenously administered after surgery improves the time to ambulation and significantly reduces pain scores in the patients, as compared to such patients receiving opioid analgesics without said administration of ibuprofen.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2026
From: CUMBERLAND PHARMACEUTICALS INC.
To: APOTEX CORP.
Reel/Frame 075763/0709 →
CORRECTIVE ASSIGNMENT TO CORRECT THE "INC." INADVERTENTLY OMITTED AFTER NAME OF RECEIVING PARTY "CUMBERLAND PHARMACEUTICALS" PREVIOUSLY RECORDED ON REEL 24078 FRAME 294. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 9, 2026
From: PAVLIV, LEO
To: CUMBERLAND PHARMACEUTICALS INC.
Reel/Frame 075506/0995 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2010
From: PAVLIV, LEO
To: CUMBERLAND PHARMACEUTICALS
Reel/Frame 024078/0293 →
Continuity (2)
Provisional Application 61159585 · Mar 12, 2009
Related Publication 20100234465A1 · Sep 16, 2010